SCHEMBL9057380

SCHEMBL9057380

COC(=O)C1=C(Cc2ccc(Br)cc2)NN(CC(F)(F)F)C1C

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
MEN1 O00255 2/20 0.35
LMNA P02545 4/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
L3MBTL1 Q9Y468 4/20 0.33
HPGD P15428 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
CASP3 P42574 1/20 0.32
ATM Q13315 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 2/20 0.32
GAA P10253 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9056577 0.86 KMT2A (0.37) KMT2ATDP1MEN1LMNASMN1; SMN2
SCHEMBL9056198 0.84 LMNA (0.37) KMT2ATDP1MEN1LMNASMN1; SMN2
SCHEMBL9056202 0.82 SMN1; SMN2 (0.36) KMT2ATDP1MEN1LMNASMN1; SMN2
SCHEMBL9057474 0.80 POLB (0.39) KMT2ATDP1LMNASMN1; SMN2L3MBTL1
SCHEMBL9057490 0.76 TDP1 (0.38) KMT2ATDP1MEN1LMNASMN1; SMN2
SCHEMBL9057492 0.76 KMT2A (0.35) KMT2ATDP1MEN1LMNASMN1; SMN2
SCHEMBL9056310 0.74 SMN1; SMN2 (0.36) KMT2ATDP1MEN1LMNASMN1; SMN2
SCHEMBL9056909 0.72 SMN1; SMN2 (0.35) KMT2ATDP1MEN1LMNASMN1; SMN2
SCHEMBL9056763 0.68 CNR2 (0.35) KMT2ATDP1MEN1LMNAL3MBTL1
SCHEMBL9057384 0.68 TDP1 (0.39) KMT2ATDP1MEN1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996004273-A1 NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST J. URIACH & CIA, S.A. (ES) 1996-02-15 WO disclosed